This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Petteri Paassilta: Innovator in Genetic Detection
Introduction
Petteri Paassilta is a notable inventor based in Oulu, Finland. He has made significant contributions to the field of genetics, particularly in the detection of altered gene sequences. His work has implications for diagnosing various pathological conditions associated with collagen protein chains.
Latest Patents
Petteri Paassilta holds a patent for "Compositions and methods for detecting altered COL1A1 gene sequences." This patent describes compositions and methods useful for determining whether a subject has an alteration in a gene encoding a protein chain of Type I or Type IX collagen. The invention includes novel intronic sequences of five human genes: COL1A1, COL1A2, COL9A1, COL9A2, and COL9A3. The methods provided can determine the existence of pathological conditions associated with altered genes, including diseases such as osteoporosis, osteoarthritis, and osteogenesis imperfecta.
Career Highlights
Throughout his career, Petteri Paassilta has focused on advancing genetic research and diagnostics. His innovative approaches have contributed to a better understanding of genetic predispositions to various diseases. His patent is a testament to his expertise and dedication to improving health outcomes through genetic detection.
Collaborations
Petteri has collaborated with esteemed colleagues in the field, including Darwin J Prockop and Loretta D Spotila. These collaborations have further enriched his research and expanded the impact of his work in genetic diagnostics.
Conclusion
Petteri Paassilta's contributions to genetic detection highlight the importance of innovation in healthcare. His patent for detecting altered COL1A1 gene sequences represents a significant advancement in the field, with the potential to improve diagnostic and prognostic capabilities for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile